Is Pro Medicus (ASX:PME) a Buy After the 34% Pullback?
Pro Medicus slips, growth momentum remains Pro Medicus (ASX: PME) has dropped approximately 34% from its record high of A$336…
Regis Healthcare (ASX:REG) Drops Below $7.20 on CEO Exit: A Buying Opportunity?
Regis Healthcare CEO Exit: What Investors Watch Next Regis Healthcare (ASX: REG) shares fell 2.6% to A$7.13 after CEO Dr…
NEXTDC or Coreweave, which is the better long-term Investment
Two Roads to Data Dominance Many investors, particularly those focused on growth and technology, already understand that data and the…
Meteoric Resources (ASX:MEI) Surges 28% as Caldeira Wins Key Environmental Approval
Investors Reprice Meteoric Resources After Caldeira Rare Earths Licence Meteoric Resources (ASX:MEI) has seen a sharp rerating this month, with…
Is Telix Pharmaceuticals (ASX:TLX) Now Undervalued With Phase 3 China Clinical Success?
Why Telix Pharmaceuticals Pullback Could Be a Second Chance Telix Pharmaceuticals (ASX:TLX) has faced a challenging year, particularly for a…
Can AI predict future stock returns? Here’s what the statistics suggest!
Can AI predict future stock returns? Some might say yes, and even that artificial intelligence can outperform human analysts. Certainly,…
ASX Casino Stock Investment Analysis Guide
Investing in ASX-listed casino stocks demands a unique blend of market analysis and sector-specific insight. It is a high-stakes game…
Channel Infrastructure NZ (ASX:CHI): Another Kiwi company just joined the ASX, but this one is the nation’s largest fuel supplier
Last Friday, Channel Infrastructure NZ listed on the ASX as a dual-listing. It is unlike the bulk of Kiwi companies…
Arafura Rare Earths (ASX:ARU) Nears FID With $1.35 Billion Secured- Time to Buy?
Arafura Rare Earths (ASX: ARU) presents one of the most puzzling setups on the ASX right now. The company has…
Mesoblast (ASX:MSB) Reaches Multi-Year High as Ryoncil Revenue Targets US$30M: Is It Still a Buy?
Commercial momentum builds as Mesoblast targets two major 2026 catalysts: Adult label expansion and Revascor BLA filing. Mesoblast (ASX: MSB)…
TechnologyOne (ASX: TNE) Wins $54.7M Legal Battle: Is the 34% Dip Now a Buying Opportunity?
TechnologyOne (ASX: TNE) has finally put one of Australia’s longest-running employment disputes behind it. The Federal Court threw out a…
Austal (ASX: ASB) Secures A$1bn Defence Win: A Defensive Buy at 28x Earnings?
Austal (ASX: ASB) locked in more than A$1.16 billion in new contracts last week, cementing its position as Australia’s go-to…
Develop Global Wins $200m OceanaGold Contract- What It Means for Investors
Develop Global (ASX: DVP) climbed 4% to A$4.36 on Friday after securing a A$200 million underground development contract with global…